Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 7,825-7,836 of 10,612

Drug study icon

CompletedNCT02559973

Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Indivior Inc.
Condition: Addiction

Drug study icon

CompletedNCT04709224

Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT04231539

Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 55 Years

Countries: United States
Sponsor: Roswell Park Cancer Institute
Condition: Addiction

Drug study icon

CompletedNCT01519557

Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Schizophrenia

Drug study icon

CompletedNCT04414930

Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: University of California, San Diego
Condition: Schizophrenia

Drug study icon

TerminatedNCT04277936

Pharmacologic Modulation of Hippocampal Activity in Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Vanderbilt University Medical Center
Condition: Schizophrenia

Drug study icon

CompletedNCT01652378

Pharmacologic MRI in Cocaine Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 64 Years

Countries: United States
Sponsor: University of Texas Southwestern Medical Center
Condition: Addiction

Drug study icon

CompletedNCT00078767

Pharmacologic Treatment of PTSD in Sexually Abused Children

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 10 Years to 17 Years

Countries: United States
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Condition: PTSD

Behavioral study icon

CompletedNCT01517360

Pharmacological Approach to Improve the Outcome of Social Cognition Training

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaBehavioralFrom 18 Years to 55 Years

Countries: United States
Sponsor: VA Greater Los Angeles Healthcare System
Condition: Schizophrenia

Drug study icon

CompletedNCT04559529

Pharmacological Modulation of Hippocampal Activity in Psychosis 2

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Vanderbilt University Medical Center
Condition: Schizophrenia

Behavioral study icon

CompletedNCT02210195

Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 70 Years

Countries: United States
Sponsor: The Scripps Research Institute
Condition: Addiction

Behavioral study icon

CompletedNCT02634684

Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaBehavioralFrom 18 Years to 55 Years

Countries: United States
Sponsor: University of California, San Diego
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.